| Sunrise Med Service Group Corp | |
| 370 Camino Gardens Blvd, Ste 102b, Boca Raton, Florida 33432 | |
| (561) 827-4815 |
| Name | Sunrise Med Service Group Corp |
|---|---|
| Organization Name | Sunrise Med Service Group Corp |
| Location | 370 Camino Gardens Blvd, Ste 102b, Boca Raton, Florida 33432 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (561) 827-4815 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
When a whole country's public health is at stake, making the wrong policy choices can cost lives and money. That's why researchers have worked to develop computer simulations of epidemics that can model individual behaviors and interactions to predict the spread of disease and the efficacy of interventions.
Data being presented at the 112th Annual Scientific Meeting of the American Urological Association shows harmful links between the use of e-cigarettes and bladder cancer risk, and associates the intensity of smoking traditional cigarettes to a higher risk of mortality among bladder cancer patients
Professor Paul Bissell's recent articles have cast doubt on patient and public involvement as a means of bringing real-world experience to treatments.
Amgen today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care compared to BSC alone. The analysis used massively parallel, next-generation sequencing technology to investigate whether mutations in nine genes known to be mutated in colorectal cancer, including the previously unanalyzed exon 3 mutation of the KRAS gene, are predictive of response to Vectibix in metastatic colorectal cancer.
› Verified 8 days ago
| NPI Number | 1538792981 |
| Organization Name | SUNRISE MED SERVICE GROUP CORP |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 370 Camino Gardens Blvd Ste 102b, Boca Raton, FL 33432 |
| Phone Number | 561-827-4815 |
News Archive
When a whole country's public health is at stake, making the wrong policy choices can cost lives and money. That's why researchers have worked to develop computer simulations of epidemics that can model individual behaviors and interactions to predict the spread of disease and the efficacy of interventions.
Data being presented at the 112th Annual Scientific Meeting of the American Urological Association shows harmful links between the use of e-cigarettes and bladder cancer risk, and associates the intensity of smoking traditional cigarettes to a higher risk of mortality among bladder cancer patients
Professor Paul Bissell's recent articles have cast doubt on patient and public involvement as a means of bringing real-world experience to treatments.
Amgen today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care compared to BSC alone. The analysis used massively parallel, next-generation sequencing technology to investigate whether mutations in nine genes known to be mutated in colorectal cancer, including the previously unanalyzed exon 3 mutation of the KRAS gene, are predictive of response to Vectibix in metastatic colorectal cancer.
› Verified 8 days ago
News Archive
When a whole country's public health is at stake, making the wrong policy choices can cost lives and money. That's why researchers have worked to develop computer simulations of epidemics that can model individual behaviors and interactions to predict the spread of disease and the efficacy of interventions.
Data being presented at the 112th Annual Scientific Meeting of the American Urological Association shows harmful links between the use of e-cigarettes and bladder cancer risk, and associates the intensity of smoking traditional cigarettes to a higher risk of mortality among bladder cancer patients
Professor Paul Bissell's recent articles have cast doubt on patient and public involvement as a means of bringing real-world experience to treatments.
Amgen today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care compared to BSC alone. The analysis used massively parallel, next-generation sequencing technology to investigate whether mutations in nine genes known to be mutated in colorectal cancer, including the previously unanalyzed exon 3 mutation of the KRAS gene, are predictive of response to Vectibix in metastatic colorectal cancer.
› Verified 8 days ago
Integra Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 399 Camino Gardens Blvd, Boca Raton, Florida 33432 Phone: (561) 440-8550 | |
Boca Medical Supply Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 620 Glades Rd, Boca Raton, Florida 33431 Phone: (561) 368-7430 | |
Boca Medical Supply Llc Type: Medicare Supplier Location: 1307 W Palmetto Park Rd, Boca Raton, Florida 33486 Phone: (561) 368-7430 | |
Publix Pharmacy #0428 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3003 Yamato Rd, Boca Raton, Florida 33434 Phone: (561) 998-1652 | |
Publix Pharmacy #1361 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7060w Palmetto Park Rd, Boca Raton, Florida 33433 Phone: (561) 338-4785 |